Bridgeway Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.78M Sell
28,500
-12,000
-30% -$758K 0.03% 572
2026
Q2
$2.33M Buy
40,500
+3,000
+8% +$172K 0.04% 521
2026
Q1
$2.27M Hold
37,500
– – 0.05% 494
2025
Q4
$2.02M Sell
37,500
-300
-0.8% -$14.4K 0.04% 535
2025
Q3
$1.7M Hold
37,800
– – 0.04% 587
2025
Q2
$1.75M Sell
37,800
-400
-1% -$19.6K 0.04% 550
2025
Q1
$2.33M Buy
+38,200
New +$2.23M 0.06% 451
2024
Q4
– Sell
-29,700
Closed -$1.54M – 1212
2024
Q3
$1.54M Sell
29,700
-2,179
-7% -$102K 0.03% 574
2024
Q2
$1.32M Buy
+31,879
New +$1.43M 0.03% 611
2022
Q4
– Sell
-150,379
Closed -$10.7M – 1380
2022
Q3
$10.7M Sell
150,379
-86,800
-37% -$6.3M 0.29% 65
2022
Q2
$18.3M Sell
237,179
-32,300
-12% -$2.46M 0.42% 17
2022
Q1
$19.7M Sell
269,479
-24,850
-8% -$1.67M 0.38% 26
2021
Q4
$18.4M Buy
294,329
+8,800
+3% +$516K 0.34% 45
2021
Q3
$16.9M Sell
285,529
-31,700
-10% -$2.09M 0.32% 55
2021
Q2
$21.2M Sell
317,229
-2,325
-0.7% -$152K 0.38% 46
2021
Q1
$20.2M Buy
319,554
+97,125
+44% +$6.04M 0.38% 50
2020
Q4
$13.8M Sell
222,429
-194,800
-47% -$12M 0.29% 101
2020
Q3
$25.2M Buy
+417,229
New +$25.1M 0.58% 28
2016
Q4
– Sell
-3,879
Closed -$209K – 1409
2016
Q3
$209K Hold
3,879
– – ﹤0.01% 1311
2016
Q2
$285K Hold
3,879
– – ﹤0.01% 1228
2016
Q1
$248K Buy
+3,879
New +$245K ﹤0.01% 1260

Other funds holding BMY

Bridgeway Capital Management's BMY Position: Q3 2026 in Review

Bridgeway Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 30% in Q3 2026, selling an estimated $758K and leaving 28,500 shares worth $1.78M. The position accounts for 0.03% of the portfolio, ranked #572.

Bridgeway Capital Management first reported a position in BMY in Q1 2016 and has held it in 21 quarters since. The position peaked at $25.2M in Q3 2020. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Bridgeway Capital Management held 28,500 shares of Bristol-Myers Squibb worth $1.78M as of Q3 2026.
  • Bridgeway Capital Management sold 12,000 Bristol-Myers Squibb shares in Q3 2026, an estimated $758K.
  • Bristol-Myers Squibb made up 0.03% of Bridgeway Capital Management's portfolio in Q3 2026, its #572 holding.
  • Bridgeway Capital Management first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 21 quarters since.
  • Bridgeway Capital Management's Bristol-Myers Squibb position peaked at $25.2M in Q3 2020.
  • 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.